Cargando…

Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes

AIMS: Metformin is the most widely used oral anti‐diabetes agent and has considerable benefits over other therapies, yet 20–30% of people develop gastrointestinal side effects, and 5% are unable to tolerate metformin due to the severity of these side effects. The mechanism for gastrointestinal side...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dujic, T., Causevic, A., Bego, T., Malenica, M., Velija‐Asimi, Z., Pearson, E. R., Semiz, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064645/ https://www.ncbi.nlm.nih.gov/pubmed/26605869 http://dx.doi.org/10.1111/dme.13040

Ejemplares similares

Association of FTO Gene Variant (rs8050136) with Type 2 Diabetes and Markers of Obesity, Glycaemic Control and Inflammation
por: Bego, Tamer, et al.
Publicado: (2019)

Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus
por: Malenica, Maja, et al.
Publicado: (2016)

Association between 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population
por: Dujic, Tanja, et al.
Publicado: (2012)

Effect of Cigarette Smoking on Haematological Parameters in Healthy Population
por: Malenica, Maja, et al.
Publicado: (2017)

Pharmacogenetics and personalized treatment of type 2 diabetes
por: Semiz, Sabina, et al.
Publicado: (2013)

Anaphylaxis during specific subcutaneous immunotherapy against ragweed allergen -- case record
por: Prnjavorac, Besim, et al.
Publicado: (2014)

IDegLira Improves Metabolic Control in Patients with Type 2 Diabetes Previously Treated with Premix Insulin
por: Bostandzic, Amela Dizdarevic, et al.
Publicado: (2022)

Diabetes - a Consequence of COVID-19 Infection
por: Burekovic, Azra, et al.
Publicado: (2022)

Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐Analysis
por: Dujic, T, et al.
Publicado: (2017)

Costs of Diabetes Mellitus and Its Complications in Bosnia and Herzegovina
por: Catic, Tarik, et al.
Publicado: (2022)

Abstract #1004269: Subacute Thyroiditis in Patients Infected with SARS-COV-2
por: Asimi, Zelija Velija, et al.
Publicado: (2021)

Principal component analysis of the oxidative stress, inflammation, and dyslipidemia influence in patients with different levels of glucoregulation
por: Malenica, Maja, et al.
Publicado: (2023)

Assessment of hematologic indices and their correlation to hemoglobin A1c among Bosnian children with type 1 diabetes mellitus and their healthy peers
por: Tihić-Kapidžić, Suzana, et al.
Publicado: (2021)

Interaction between Omeprazole and Gliclazide in Relation to CYP2C19 Phenotype
por: Dujic, Tanja, et al.
Publicado: (2021)

Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
por: Nies, Anne T., et al.
Publicado: (2011)

Cardiovascular Risk Factors in Patients with Poorly Controlled Diabetes Mellitus
por: Dizdarevic-Bostandzic, Amela, et al.
Publicado: (2018)

Rescue of Misfolded Organic Cation Transporter 3 Variants
por: Angenoorth, Thomas J. F., et al.
Publicado: (2022)

Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients
por: Siavash, Mansour, et al.
Publicado: (2017)

Mediterranean Diet and Type 2 Diabetes Mellitus: A Perpetual Inspiration for the Scientific World. A Review
por: Milenkovic, Tatjana, et al.
Publicado: (2021)

Metformin and the gastrointestinal tract
por: McCreight, Laura J., et al.
Publicado: (2016)

Association between the synonymous variant organic cation transporter 3 (OCT3)-1233G>A and the glycemic response following metformin therapy in patients with type 2 diabetes
por: Hosseyni-Talei, Seyyedeh Raheleh, et al.
Publicado: (2017)

Association of Inherited Genotype and Severity of Clinical Presentation in Subjects with Verified Pas III Disorder
por: Beslic, Vanja Karlovic, et al.
Publicado: (2022)

Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates
por: Hacker, Kristina, et al.
Publicado: (2015)

Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 & 2 and AMP-activated Protein Kinase in the Kidney
por: Christensen, Michael, et al.
Publicado: (2016)

Extended Intake of Mulberry Leaf Extract Delayed Metformin Elimination via Inhibiting the Organic Cation Transporter 2
por: Huh, Hyun Wook, et al.
Publicado: (2020)

Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review
por: Mofo Mato, Edith Pascale, et al.
Publicado: (2018)

Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
por: Zhou, Kaixin, et al.
Publicado: (2009)

Interaction of Masitinib with Organic Cation Transporters
por: Harrach, Saliha, et al.
Publicado: (2022)

Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
por: Kawoosa, Fizalah, et al.
Publicado: (2022)

Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol
por: Mato, Edith Pascale Mofo, et al.
Publicado: (2018)

Pharmacokinetics of metformin in patients with gastrointestinal intolerance
por: McCreight, Laura J., et al.
Publicado: (2018)

Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations
por: Ciarimboli, Giuliano
Publicado: (2021)

Atypical Substrates of the Organic Cation Transporter 1
por: Redeker, Kyra-Elisa Maria, et al.
Publicado: (2022)

Regulation of Transporters for Organic Cations by High Glucose
por: Steinbüchel, Martin, et al.
Publicado: (2023)

Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects
por: Schweighofer, Natascha, et al.
Publicado: (2023)

Genetic Association of Solute Carrier Transporter Gene Variants with Metformin Response
por: Abrahams-October, Z, et al.
Publicado: (2021)

Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities
por: Doetsch, David A., et al.
Publicado: (2022)

Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?
por: Wenzel, Christoph, et al.
Publicado: (2021)

Structural basis of promiscuous substrate transport by Organic Cation Transporter 1
por: Zeng, Yi C., et al.
Publicado: (2023)

A phosphotyrosine switch regulates organic cation transporters
por: Sprowl, Jason A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nv4dsalqimnm24j7i509kui8nd